ARVINAS, INC. (ARVN)
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Visa and Brale Explore Private Stablecoin Settlement for Institutional Payments
Lamb Weston Announces Intention to Close Broekhuizenvorst Production Facility in the Netherlands
Fifth Third for Business Helps Small Businesses Get Paid Faster, Manage Cash Flow, and Access Capital
One NZ Sets New Telco Industry Benchmark with UiPath, Accelerating Enterprise Mobile Provisioning from Days to Minutes
Cimpress to Present at the 16th Annual East Coast Ideas Conference on June 11, 2026 in New York
LanzaTech JV Successful IPO Underscores Strategic Value of More Secure Fuel Supply
DevvStream Announces $6 Million Equity Investment from EEME Energy; Gives Notice to Terminate $300 Million Equity Line of Credit
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers